Global Recombinant Cell Culture Supplements Market, By Products ; By Application ; By Expression System ; By Region ; Trend Analysis, Competitive Market Share & Forecast, 2022-2028

Description

Global Recombinant Cell Culture Supplements Market to Witness a CAGR of 12.5% during Forecast Period

Global Recombinant Cell Culture Supplements Market is growing at a high CAGR because of the rising investments in life sciences research and development. The increased preference and use of animal-free supplements is also driving the global recombinant cell culture supplements market.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Recombinant Cell Culture Supplements Market was worth USD 309.3 million in the year 2021. The market is projected to grow at a CAGR of 12.5%, earning revenues of around USD 702.5 million by 2028. The global recombinant cell culture supplements market is booming because of the increasing investment in drug research and development coupled with the rising demand for cell culture supplements. Moreover, the advantages of animal-free biotherapeutics and biopharmaceuticals over traditional animal-derived supplements are driving the growth of the global recombinant cell culture supplements market during the forecast period 2022-2028.

Rising Demand for Recombinant Cell Culture Supplements to Drive the Market Growth

Over the years, the demand for recombinant cell culture supplements has risen. This is because cell culture is an integral part of drug research and development, and manufacturing. With the increasing population, humanity is seeing the advent of novel viruses, fungi, and bacteria, causing diseases. To save humanity against acute and chronic, infectious and non-infectious, communicable and non-communicable diseases, it is essential to invent and produce a variety of recombinant proteins, vaccines, diagnostic reagents, advanced therapies, and biotherapeutics and biopharmaceuticals. They are produced using prokaryotic (bacteria, yeast cells) and eukaryotic (mammalian cells, transgenic plants) expression host systems in large-scale settings. These therapeutic and prophylactic recombinant proteins are produced by continuous upstream processing, continuous chromatography, integrated continuous bioprocessing, etc., to achieve high quality and quantity of proteins. The increased production to fulfill the high demand is expected to bolster the growth of the market in the forecast period.

Global Recombinant Cell Culture Supplements Market - By Product

Based on products, the global recombinant cell culture supplements market is segmented into recombinant growth factors, recombinant insulin, recombinant albumin, recombinant transferrin, recombinant trypsin, recombinant aprotinin, recombinant lysozyme, and others. Amidst the segmentation, the recombinant albumin (rAlbumin) segment is expected to grow with the highest CAGR during the forecast period 2022-2028 because albumin is a widely used nutrient in all cells cultures; for example, the production of monoclonal antibodies.

Global Recombinant Cell Culture Supplements Market - Regional Insights

Based on regions, the global recombinant cell culture supplements market has been segmented into five categories- North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Amidst the segmentation, North America dominated the global Recombinant Cell Culture Supplements market share in 2021 due to the availability of appropriate technology and sufficient funding. On the other hand, Europe is estimated to grow at the highest rate due to a large number of recombinant cell culture supplement products and manufacturing units, biopharmaceutical organizations and research institutes, and increased government funds for cell science research organizations.

Impact of COVID-19 on Global Recombinant Cell Culture Supplements Market

As a result of the COVID-19 pandemic, worldwide lockdowns were imposed, and manufacturing and operations were seriously affected. This hampered the ongoing research and clinical development of various biopharmaceutical products. To prevent infection from the notorious SARS-CoV-2, research grants were given out for the research and development of Covid vaccines. In the later phases of the pandemic, the government's emphasis shifted on building a robust supply chain for the transportation of Covid test kits, diagnostics, drugs, vaccines, and recombinant supplements. Due to the recommencement of sales for research purposes, the recombinant cell culture supplement-producing firms were able to maintain their financial position.

Competitive Landscape

Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences Inc., GE Healthcare, Novozymes A/S, Advanced Biotechnologies Inc., Lonza, STEMCELL Technologies Inc., PeproTech Inc., Sino Biological Inc., FUJIFILM Irvine Scientific, Evercyte GmbH, Kingfisher Biotech Inc. In March 2022, Thermo Fisher Scientific acquired PeproTech, a company that specializes in the development and manufacturing of recombinant proteins, for USD 1.85 billion. The companies aim to expand their business by setting up more manufacturing plants to gain a significant market share. For example, in May 2022, FUJIFILM Irvine Scientific built a new bioprocessing center in China. They also constructed a new cell culture media manufacturing facility in the Netherlands in June 2019.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global recombinant cell culture supplements market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global recombinant cell culture supplements market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC22321

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Research Methodology

2.1. Qualitative Research
- 2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
- 2.3.1. Secondary Research
- 2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation

3. Executive Summary

4. Global Recombinant Cell Culture Supplements Market Insights

4.1. Industry Value Chain Analysis
4.2. DROC Analysis
- 4.2.1. Growth Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
4.3. Technological Advancement/Recent Development
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
- 4.5.1. Bargaining Power of Suppliers
- 4.5.2. Bargaining Power of Buyers
- 4.5.3. Threat of New Entrants
- 4.5.4. Threat of Substitutes
- 4.5.5. Intensity of Rivalry

5. Global Recombinant Cell Culture Supplements Market Overview

5.1. Market Size & Forecast by Value, 2018-2028
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Products
  - 5.2.1.1. Recombinant Growth Factors
  - 5.2.1.2. Recombinant Insulin
  - 5.2.1.3. Recombinant Albumin
  - 5.2.1.4. Recombinant Transferrin
  - 5.2.1.5. Recombinant Trypsin
  - 5.2.1.6. Recombinant Aprotinin
  - 5.2.1.7. Recombinant Lysozyme
  - 5.2.1.8. Others
- 5.2.2. By Application
  - 5.2.2.1. Stem Cell and Regenerative Medicine
  - 5.2.2.1.1. Stem Cell Therapy
  - 5.2.2.1.2. Cell Therapy
  - 5.2.2.1.3. Gene Therapy
  - 5.2.2.2. Bio-Production
  - 5.2.2.2.1. Monoclonal Antibodies
  - 5.2.2.2.2. Recombinant Proteins
  - 5.2.2.2.3. Vaccines
  - 5.2.2.2.4. Hormones
  - 5.2.2.2.5. Other Biological Products
  - 5.2.2.3. Academic and Research Application
- 5.2.3. By Expression System
  - 5.2.3.1. Mammalian
  - 5.2.3.2. E. Coli
  - 5.2.3.3. Yeast
  - 5.2.3.4. Others
- 5.2.4. By Region
  - 5.2.4.1. North America
  - 5.2.4.2. Europe
  - 5.2.4.3. The Asia Pacific
  - 5.2.4.4. Latin America
  - 5.2.4.5. The Middle East and Africa

6. North America Recombinant Cell Culture Supplements Market

6.1. Market Size & Forecast by Value, 2018-2028
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Products
- 6.2.2. By Application
- 6.2.3. By Expression System
- 6.2.4. By Country
  - 6.2.4.1. United States
  - 6.2.4.2. Canada

7. Europe Recombinant Cell Culture Supplements Market

7.1. Market Size & Forecast by Value, 2018-2028
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Products
- 7.2.2. By Application
- 7.2.3. By Expression System
- 7.2.4. By Country
  - 7.2.4.1. Germany
  - 7.2.4.2. United Kingdom
  - 7.2.4.3. Italy
  - 7.2.4.4. France
  - 7.2.4.5. Spain
  - 7.2.4.6. Rest of Europe

8. The Asia Pacific Recombinant Cell Culture Supplements Market

8.1. Market Size & Forecast by Value, 2018-2028
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Products
- 8.2.2. By Application
- 8.2.3. By Expression System
- 8.2.4. By Country
  - 8.2.4.1. China
  - 8.2.4.2. India
  - 8.2.4.3. Japan
  - 8.2.4.4. Australia
  - 8.2.4.5. South Korea
  - 8.2.4.6. Rest of Asia Pacific

9. Latin America Recombinant Cell Culture Supplements Market

9.1. Market Size & Forecast by Value, 2018-2028
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Products
- 9.2.2. By Application
- 9.2.3. By Expression System
- 9.2.4. By Country
  - 9.2.4.1. Brazil
  - 9.2.4.2. Mexico
  - 9.2.4.3. Rest of Latin America

10. The Middle East & Africa Recombinant Cell Culture Supplements Market

10.1. Market Size & Forecast by Value, 2018-2028
- 10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
- 10.2.1. By Products
- 10.2.2. By Application
- 10.2.3. By Expression System
- 10.2.4. By Country
  - 10.2.4.1. Saudi Arabia
  - 10.2.4.2. UAE
  - 10.2.4.3. Turkey
  - 10.2.4.4. South Africa
  - 10.2.4.5. Rest of Middle East & Africa

11. Competitive Landscape

11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2028
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)

12. Impact of Covid-19 on Global Recombinant Cell Culture Supplements Market Industry

13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

13.1. Thermo Fisher Scientific Inc.
13.2. Merck KGaA
13.3. Becton
13.4. Dickinson and Company
13.5. Hi-Media Laboratories
13.6. Sartorius AG
13.7. InVitro
13.8. SeraCare Life Sciences Inc.
13.9. GE Healthcare
13.10. Novozymes A/S
13.11. Advanced Biotechnologies Inc.
13.12. Lonza
13.13. STEMCELL Technologies Inc.
13.14. PeproTech Inc.
13.15. Sino Biological Inc.
13.16. FUJIFILM Irvine Scientific
13.17. Evercyte GmbH
13.18. Kingfisher Biotech Inc.
13.19. Other prominent players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List Of Figures

Figure 1 Global Recombinant Cell Culture Supplements Segmentation
Figure 2 Global Recombinant Cell Culture Supplements Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2021
Figure 4 Global Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 5 Global Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 6 Global Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 7 Global Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 8 Global Recombinant Cell Culture Supplements Market Share, By Region, By Value, 2018-2028
Figure 9 North America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 10 North America Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 11 North America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 12 North America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 13 North America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028
Figure 14 Europe Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 15 Europe Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 16 Europe Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 17 Europe Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 18 Europe Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028
Figure 19 The Asia-Pacific Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 20 The Asia-Pacific Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 21 The Asia-Pacific Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 22 The Asia-Pacific Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 23 The Asia-Pacific Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028
Figure 24 Latin America Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 25 Latin America Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 26 Latin America Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 27 Latin America Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 28 Latin America Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028
Figure 29 The Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Value (USD Million), 2018-2028
Figure 30 The Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Products, By Value, 2018-2028
Figure 31 The Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Application, By Value, 2018-2028
Figure 32 The Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Expression System, By Value, 2018-2028
Figure 33 The Middle East & Africa Recombinant Cell Culture Supplements Market Share, By Country, By Value, 2018-2028

List Of Tables

Table 1 Global Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 2 Global Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 3 Global Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 4 Global Recombinant Cell Culture Supplements Market Size, By Region, By Value, 2018-2028
Table 5 North America Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 6 North America Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 7 North America Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 8 North America Recombinant Cell Culture Supplements Market Size, By Country, By Value, 2018-2028
Table 9 Europe Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 10 Europe Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 11 Europe Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 12 Europe Recombinant Cell Culture Supplements Market Size, By Country, By Value, 2018-2028
Table 13 The Asia-Pacific Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 14 The Asia-Pacific Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 15 The Asia-Pacific Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 16 The Asia-Pacific Recombinant Cell Culture Supplements Market Size, By Country, By Value, 2018-2028
Table 17 Latin America Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 18 Latin America Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 19 Latin America Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 20 Latin America Recombinant Cell Culture Supplements Market Size, By Country, By Value, 2018-2028
Table 21 The Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Products, By Value, 2018-2028
Table 22 The Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Application, By Value, 2018-2028
Table 23 The Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Expression System, By Value, 2018-2028
Table 24 The Middle East & Africa Recombinant Cell Culture Supplements Market Size, By Country, By Value, 2018-2028
Table 25 Thermo Fisher Scientific Inc. Company Overview
Table 26 Thermo Fisher Scientific Inc. Financial Overview
Table 27 Merck KGaA Company Overview
Table 28 Merck KGaA Financial Overview
Table 29 Becton Company Overview
Table 30 Becton Financial Overview
Table 31 Dickinson and Company Company Overview
Table 32 Dickinson and Company Financial Overview
Table 33 Hi-Media Laboratories Company Overview
Table 34 Hi-Media Laboratories Financial Overview
Table 35 Sartorius AG Company Overview
Table 36 Sartorius AG Financial Overview
Table 37 InVitro Company Overview
Table 38 InVitro Financial Overview
Table 39 SeraCare Life Sciences Inc. Company Overview
Table 40 SeraCare Life Sciences Inc. Financial Overview
Table 41 GE Healthcare Company Overview
Table 42 GE Healthcare Financial Overview
Table 43 Novozymes A/S Company Overview
Table 44 Novozymes A/S Financial Overview
Table 45 Advanced Biotechnologies Inc. Company Overview
Table 46 Advanced Biotechnologies Inc. Financial Overview
Table 47 Lonza Company Overview
Table 48 Lonza Financial Overview
Table 49 STEMCELL Technologies Inc. Company Overview
Table 50 STEMCELL Technologies Inc. Financial Overview
Table 51 PeproTech Inc. Company Overview
Table 52 PeproTech Inc. Financial Overview
Table 53 Sino Biological Inc. Company Overview
Table 54 Sino Biological Inc. Financial Overview
Table 55 FUJIFILM Irvine Scientific Company Overview
Table 56 FUJIFILM Irvine Scientific Financial Overview
Table 57 Evercyte GmbH Company Overview
Table 58 Evercyte GmbH Financial Overview
Table 59 Kingfisher Biotech Inc. Company Overview
Table 60 Kingfisher Biotech Inc. Financial Overview